Related Experiment Video
Updated: Jun 7, 2025

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.3K
Increased cell killing effect in neutron capture enhanced proton beam therapy
Shintaro Shiba1,2,3, Takahiro Shimo4, Masashi Yamanaka4
1Department of Radiation Oncology, Shonan Kamakura General Hospital, 1370-1, Okamoto, Kamakura, Kanagawa, 247-8533, Japan. shiba4885@yahoo.co.jp.
Scientific Reports
|November 18, 2024
Summary
Neutron capture enhanced proton beam therapy (NCEPBT) increases the cell killing effect on various cancer cells. Higher boron concentrations in NCEPBT significantly enhance its efficacy, showing promise for clinical applications.
Area of Science:
- Oncology
- Medical Physics
- Radiotherapy
Background:
- Proton beam therapy (PBT) generates thermal neutrons.
- Neutron capture reactions with boron are proposed for enhanced PBT (NCEPBT).
- The cell killing effect of NCEPBT requires further investigation.
Purpose of the Study:
- To evaluate the cell killing effect of NCEPBT.
- To determine the impact of boron concentration on NCEPBT efficacy.
- To assess the relative biological effectiveness (RBE) of NCEPBT.
Main Methods:
- Monte Carlo simulations to model neutron distribution.
- Irradiation of human cancer cell lines (HSG, MG63, SAS, G-361) with X-rays, PBT, and NCEPBT.
- Varying boronophenylalanine concentrations (20 and 80 ppm) during NCEPBT.
Main Results:
- Neutrons from PBT were uniformly distributed in simulations.
- NCEPBT with 80 ppm boron showed significantly higher RBE values across all tested cell lines compared to PBT alone.
- RBE values increased with higher boron concentrations, indicating enhanced cell killing.
Conclusions:
- NCEPBT demonstrates an increased cell killing effect, particularly at higher boron concentrations.
- The findings support the clinical potential of NCEPBT.
- Further research into NCEPBT is warranted for its clinical application.
Related Concept Videos
Nuclear Transmutation
17.4K
Nuclear transmutation is the conversion of one nuclide into another. It can occur by the radioactive decay of a nucleus, or the reaction of a nucleus with another particle. The first manmade nucleus was produced in Ernest Rutherford’s laboratory in 1919 by a transmutation reaction, the bombardment of one type of nuclei with other nuclei or with neutrons. Rutherford bombarded nitrogen-14 atoms with high-speed α particles from a natural radioactive isotope of radium and observed...
17.4K
Nuclear Overhauser Enhancement (NOE)
641
Irradiation of a spin-active nucleus causes an increase or decrease in the signal intensity of neighboring nuclei that are not necessarily chemically bonded or involved in J-coupling. This phenomenon, called the Nuclear Overhauser Enhancement (NOE), results from through-space interactions between the nuclear spins. The NOE effect decreases with increasing internuclear distance and is generally not observed beyond 4 angstroms. In NOE, dipole-dipole interactions between neighboring...
641
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K

